Key facts
- Algiecel’s last known valuation is $28.0M.
- It has raised $13.4M; the latest was Early Stage VC ($10.4M) in Oct 2024.
- Notable investors include European Commission, Denmark's Export and Investment Fund, BioInnovation Institute, Danish Green Investment Fund, Erhvervshus Sjælland — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Algiecel
- ·The full record, as it builds
Funding rounds
No funding rounds for Algiecel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Algiecel
Producer of low-footprint nutrient-rich microalgae ingredients intended for application in feed, food, and cosmetics. The company uses compact photobioreactor technology and utilizes carbon dioxide sourced from industrial partners to promote decarbonization, light, and microalgae to provide an optimal output, enabling feed and food industries to meet the demand for sustainable products and reduce their supply chains and overall carbon footprint profile.
- Sector
- Business Products and Services (B2B)
- HQ
- Odense, Denmark
- Founded
- 2021
- Employees
- 23
- Website
- algiecel.com/
- Ownership
- Privately Held (backing)
Algiecel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Algiecel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Algiecel in its N-PORT filings yet. We sweep new filings monthly.